Professor Samba Sow and the other WHO Special Envoys on COVID-19 recently published an important call for vaccine equity in a number of leading global publications. Their analysis is available in French, Arabic, Spanish and other languages and can be read in English on the website of The Guardian newspaper here.
Author: CVD-Mali
Categories
In praise of vaccines!
For our team here at CVD-Mali, World Immunization Week is always a notable event on the calendar. As the Center for Vaccine Development in Mali, our core work has always revolved around the development, trial and implementation of safe and effective vaccines, in Mali primarily but also in the wider West African region. This year’s […]
At CVD-Mali we are very fortunate to be working at the moment on many different health-related projects. These include vaccine development trials, a leprosy treatment trial, maternal and child health trials as well as ongoing work on surveillance and analysis of COVID-19 in Malian communities. As always, we carry out this work in conjunction with […]
The COVID-19 pandemic in Africa has arrived at a critical point. We are seeing increases in deaths and overwhelmed health systems, in countries that often lack the infrastructure to properly record cases and respond. I see on the ground the toll all this is taking – on communities, on health workers and on vulnerable populations. […]
There has not been much time for reflection this year, it has been a year of crisis and action. However, as well as carrying out our work, it is important too to take some time to pause and reflect. COVID-19 has affected the world in ways we could never have predicted, and it has been […]
I have spent a large part of my time during the last three months in the field, in various parts of rural Mali, trying to ensure that CVD-Mali’s large-scale trials are able to get up and running. I have also been working on our ongoing COVID-19 research projects and, of course, training and developing the […]
Categories
Lakana commences in Kita!
On Thursday, 15 October 2020, CVD-Mali gave the first doses of Lakana study medicine to young participants in Kita. The Lakana trial, which is being carried out with funding from the Bill & Melinda Gates Foundation, aims to assess the impact azithromycin has on mortality rates in children aged 1-11 months. The CVD-Mali team have […]